§ 13F · FUND PROFILE
Eversept Partners, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 120Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$326M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP DEL | 264K | $157M | 8.3% | +5% |
| 2 | QQQ | INVESCO QQQ TR | 239K | $138M | 7.3% | +6% |
| 3 | ABVX | ABIVAX SA | 934K | $104M | 5.5% | +42% |
| 4 | GSK | GSK PLC | 1.79M | $99M | 5.2% | −33% |
| 5 | VERA | VERA THERAPEUTICS INC | 2.17M | $87M | 4.6% | −29% |
| 6 | NTRA | NATERA INC | 385K | $77M | 4.1% | +15% |
| 7 | SPY | STATE STR SPDR S&P 500 ETF T | 107K | $70M | 3.7% | +138% |
| 8 | SNDX | SYNDAX PHARMACEUTICALS INC | 2.89M | $67M | 3.6% | −13% |
| 9 | CLDX | CELLDEX THERAPEUTICS INC NEW | 1.79M | $57M | 3.0% | +25% |
| 10 | PCVX | VAXCYTE INC | 924K | $54M | 2.8% | −23% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE EVERSEPT SIGNAL
AC read
Eversept Partners, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed